GLTO Insider Trading

Insider Ownership Percentage: 11.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $8,979.03

Galecto Insider Trading History Chart

This chart shows the insider buying and selling history at Galecto by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M-$500k$0$500k$1MTotal Insider BuyingTotal Insider Selling

Galecto Share Price & Price History

Current Price: $3.07
Price Change: Price Decrease of -0.035 (-1.13%)
As of 04/1/2025 03:03 PM ET

This chart shows the closing price history over time for GLTO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$3.10Closing price on 03/31/25:

SEC Filings (Institutional Ownership Changes) for Galecto (NASDAQ:GLTO)

14.20% of Galecto stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GLTO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$39kbought$19ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$5M$0$5MTotal InflowsTotal Outflows
Galecto logo
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
Read More on Galecto

Today's Range

Now: $3.07
Low: $3.05
High: $3.26

50 Day Range

MA: $4.60
Low: $3.10
High: $6.70

52 Week Range

Now: $3.07
Low: $3.00
High: $20.25

Volume

23,120 shs

Average Volume

74,311 shs

Market Capitalization

$4.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Who are the company insiders with the largest holdings of Galecto?

Galecto's top insider shareholders include:
  1. Orbimed Advisors Llc (Major Shareholder)
  2. Hans T Schambye (CEO)
  3. Lori Firmani (CFO)
Learn More about top insider investors at Galecto.